Skip to main content
. 2012 Jun;67(6):557–563. doi: 10.6061/clinics/2012(06)03

Table 2.

Variables defining treatment efficacy.

Variable Total(n = 206) OA Group (n = 93) NA Group (n = 113) p-value
Treatment Failure 46 (22.3%) 18 (19.3%) 28 (24.7%) 0.35
    Patient Death 31 (15.1%) 13 (13.9%) 18 (15.9%)
 Pleural Space Reintervention 19 (9.2%) 6 (6.45%) 13 (11.5%)
Cases with complications* 83 (40.2%) 45 (48.3%) 38 (33.6%) 0.04
Total number of complications 110 60 50
 Intraoperative blood transfusion 63 34 29
 DVT 4 1 3
 Prolonged air leak 13 6 7
 Chylothorax 1 0 1
 Diaphragmatic lesion 2 0 2
 High Response Atrial Fibrillation 1 1 0
 Bronchopneumonia 11 10 1
 Surgical Wound Infection 7 3 4
 Seroma 2 2 0
 Subcutaneous Emphysema 6 3 3
Operation Room time (min)+ 200.8±87 198.6±82.6 202.7±90.8 0.74
ICU postoperative stay (days) 1 (0-2) 1 (0-2) 1 (0-3) 0.045
Thoracostomy tube drainage (days) 6 (5-11) 6 (5-8) 7 (5-14) 0.09
Postoperative hospital stay (days) 9 (7-16) 8 (7-14) 10 (7-19) 0.14

The data are presented as either n (%), median ± standard deviation or p50 (p25-p75). OA, old algorithm; NA, new algorithm; ICU, intensive care unit; DVT, deep vein thrombosis; *, number of patients with at least one complication; ?time spent between the patient's entrance to and exit from the surgical room.